Cargando…
Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugs
BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are an effective and common treatment for chronic pain disorders, but long-term use is associated with risk of potentially life-threatening gastrointestinal adverse events (AEs). The proton pump inhibitor esomeprazole has been found to be ef...
Autores principales: | Sugano, Kentaro, Kinoshita, Yoshikazu, Miwa, Hiroto, Takeuchi, Tsutomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623652/ https://www.ncbi.nlm.nih.gov/pubmed/23530709 http://dx.doi.org/10.1186/1471-230X-13-54 |
Ejemplares similares
-
Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients – focus on esomeprazole
por: Tang, Raymond SY, et al.
Publicado: (2013) -
Non-Steroidal Anti-Inflammatory Drugs and Peptic Ulceration
por: Clinch, D., et al.
Publicado: (1987) -
Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)
por: Scheiman, James M, et al.
Publicado: (2011) -
An extended 36-week oral esomeprazole improved long-term recurrent peptic ulcer bleeding in patients at high risk of rebleeding
por: Chiang, Hsueh-Chien, et al.
Publicado: (2022) -
Comparison between esomeprazole 20 mg Vs 40 mg as stress ulcer prophylaxis (SUP) in critically ill patients: A retrospective cohort study
por: Al Sulaiman, Khalid, et al.
Publicado: (2020)